Joseph E Payne - Net Worth and Insider Trading
Joseph E Payne Net Worth
The estimated net worth of Joseph E Payne is at least $71 Million dollars as of 2024-06-03. Joseph E Payne is the President and CEO of Arcturus Therapeutics Holdings Inc and owns about 1,480,097 shares of Arcturus Therapeutics Holdings Inc (ARCT) stock worth over $60 Million. Joseph E Payne is also the Director of Vallon Pharmaceuticals Inc and owns about 861,250 shares of Vallon Pharmaceuticals Inc (VLON) stock worth over $10 Million. Details can be seen in Joseph E Payne's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Joseph E Payne has not made any transactions after 2022-11-23 and currently still holds the listed stock(s).
Transaction Summary of Joseph E Payne
Joseph E Payne Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Joseph E Payne owns 3 companies in total, including Arcturus Therapeutics Holdings Inc (ARCT) , Vallon Pharmaceuticals Inc (VLON) , and GRI Bio Inc (GRI) .
Click here to see the complete history of Joseph E Payne’s form 4 insider trades.
Insider Ownership Summary of Joseph E Payne
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ARCT | Arcturus Therapeutics Holdings Inc | 2022-11-23 | director & 10 percent owner & President and CEO |
| VLON | Vallon Pharmaceuticals Inc | 2021-05-26 | director |
| GRI | GRI Bio Inc | 2021-05-14 | director |
Joseph E Payne Latest Holdings Summary
Joseph E Payne currently owns a total of 2 stocks. Among these stocks, Joseph E Payne owns 1,480,097 shares of Arcturus Therapeutics Holdings Inc (ARCT) as of November 23, 2022, with a value of $60 Million and a weighting of 85.4%. Joseph E Payne also owns 861,250 shares of Vallon Pharmaceuticals Inc (VLON) as of May 26, 2021, with a value of $10 Million and a weighting of 14.6%.
Latest Holdings of Joseph E Payne
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ARCT | Arcturus Therapeutics Holdings Inc | 2022-11-23 | 1,480,097 | 40.86 | 60,476,763 |
| VLON | Vallon Pharmaceuticals Inc | 2021-05-26 | 861,250 | 12.00 | 10,335,000 |
Holding Weightings of Joseph E Payne
Joseph E Payne Form 4 Trading Tracker
According to the SEC Form 4 filings, Joseph E Payne has made a total of 3 transactions in Arcturus Therapeutics Holdings Inc (ARCT) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Arcturus Therapeutics Holdings Inc is the acquisition of 5,000 shares on November 23, 2022, which cost Joseph E Payne around $82,550.
According to the SEC Form 4 filings, Joseph E Payne has made a total of 1 transactions in Vallon Pharmaceuticals Inc (VLON) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Vallon Pharmaceuticals Inc is the acquisition of 17,500 shares on May 26, 2021, which cost Joseph E Payne around $71,750.
Insider Trading History of Joseph E Payne
- 1
Joseph E Payne Trading Performance
GuruFocus tracks the stock performance after each of Joseph E Payne's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Joseph E Payne is 10.67%. GuruFocus also compares Joseph E Payne's trading performance to market benchmark return within the same time period. The performance of stocks bought by Joseph E Payne within 3 months outperforms 3 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Joseph E Payne's insider trading performs compared to the benchmark.
Performance of Joseph E Payne
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 17.77 | | | | | |
| Relative Return to S&P 500(%) | 18.12 | | | | | |
Joseph E Payne Ownership Network
Joseph E Payne Owned Company Details
What does Arcturus Therapeutics Holdings Inc do?
Who are the key executives at Arcturus Therapeutics Holdings Inc?
Joseph E Payne is the director & 10 percent owner & President and CEO of Arcturus Therapeutics Holdings Inc. Other key executives at Arcturus Therapeutics Holdings Inc include Chief Scientific Officer & COO Pad Chivukula , See Remarks Keith C Kummerfeld , and director & 10 percent owner Ultragenyx Pharmaceutical Inc. .
Arcturus Therapeutics Holdings Inc (ARCT) Insider Trades Summary
Over the past 18 months, Joseph E Payne made no insider transaction in Arcturus Therapeutics Holdings Inc (ARCT). Other recent insider transactions involving Arcturus Therapeutics Holdings Inc (ARCT) include a net sale of 116,000 shares made by Pad Chivukula , a net sale of 13,936 shares made by Keith C Kummerfeld , and a net purchase of 2,222 shares made by Magda Marquet .
In summary, during the past 3 months, insiders sold 26,000 shares of Arcturus Therapeutics Holdings Inc (ARCT) in total and bought 0 shares, with a net sale of 26,000 shares. During the past 18 months, 129,936 shares of Arcturus Therapeutics Holdings Inc (ARCT) were sold and 2,222 shares were bought by its insiders, resulting in a net sale of 127,714 shares.
Arcturus Therapeutics Holdings Inc (ARCT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Arcturus Therapeutics Holdings Inc Insider Transactions
Joseph E Payne Mailing Address
Above is the net worth, insider trading, and ownership report for Joseph E Payne. You might contact Joseph E Payne via mailing address: 10628 Science Center Drive, Suite 200, San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
